Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients.
Dewald F, Pirkl M, Paluschinski M, Kühn J, Elsner C, Schulte B, Knüfer J, Ahmadov E, Schlotz M, Oral G, Bernhard M, Michael M, Luxenburger M, Andrée M, Hennies MT, Hafezi W, Müller MM, Kümpers P, Risse J, Kill C, Manegold RK, von Frantzki U, Richter E, Emmert D, Monzon-Posadas WO, Gräff I, Kogej M, Büning A, Baum M, Teipel F, Mochtarzadeh B, Wolff M, Gruell H, Di Cristanziano V, Burst V, Streeck H, Dittmer U, Ludwig S, Timm J, Klein F. Dewald F, et al. Among authors: di cristanziano v. Nat Commun. 2023 May 19;14(1):2835. doi: 10.1038/s41467-023-38127-y. Nat Commun. 2023. PMID: 37208323 Free PMC article. Clinical Trial.
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Kreer C, Zehner M, Weber T, Ercanoglu MS, Gieselmann L, Rohde C, Halwe S, Korenkov M, Schommers P, Vanshylla K, Di Cristanziano V, Janicki H, Brinker R, Ashurov A, Krähling V, Kupke A, Cohen-Dvashi H, Koch M, Eckert JM, Lederer S, Pfeifer N, Wolf T, Vehreschild MJGT, Wendtner C, Diskin R, Gruell H, Becker S, Klein F. Kreer C, et al. Among authors: di cristanziano v. Cell. 2020 Aug 20;182(4):843-854.e12. doi: 10.1016/j.cell.2020.06.044. Epub 2020 Jul 13. Cell. 2020. PMID: 32673567 Free PMC article.
Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay.
Schermer B, Fabretti F, Damagnez M, Di Cristanziano V, Heger E, Arjune S, Tanner NA, Imhof T, Koch M, Ladha A, Joung J, Gootenberg JS, Abudayyeh OO, Burst V, Zhang F, Klein F, Benzing T, Müller RU. Schermer B, et al. Among authors: di cristanziano v. PLoS One. 2020 Nov 2;15(11):e0238612. doi: 10.1371/journal.pone.0238612. eCollection 2020. PLoS One. 2020. PMID: 33137122 Free PMC article.
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting.
Müller L, Ostermann PN, Walker A, Wienemann T, Mertens A, Adams O, Andree M, Hauka S, Lübke N, Keitel V, Drexler I, Di Cristanziano V, Hermsen DF, Kaiser R, Boege F, Klein F, Schaal H, Timm J, Senff T. Müller L, et al. Among authors: di cristanziano v. Eur J Clin Microbiol Infect Dis. 2021 May;40(5):1063-1071. doi: 10.1007/s10096-021-04169-7. Epub 2021 Feb 3. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33534090 Free PMC article.
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG.
Eberhardt KA, Dewald F, Heger E, Gieselmann L, Vanshylla K, Wirtz M, Kleipass F, Johannis W, Schommers P, Gruell H, Brensing KA, Müller RU, Augustin M, Lehmann C, Koch M, Klein F, Di Cristanziano V. Eberhardt KA, et al. Among authors: di cristanziano v. Microorganisms. 2021 Mar 31;9(4):733. doi: 10.3390/microorganisms9040733. Microorganisms. 2021. PMID: 33807490 Free PMC article.
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.
Vanshylla K, Di Cristanziano V, Kleipass F, Dewald F, Schommers P, Gieselmann L, Gruell H, Schlotz M, Ercanoglu MS, Stumpf R, Mayer P, Zehner M, Heger E, Johannis W, Horn C, Suárez I, Jung N, Salomon S, Eberhardt KA, Gathof B, Fätkenheuer G, Pfeifer N, Eggeling R, Augustin M, Lehmann C, Klein F. Vanshylla K, et al. Among authors: di cristanziano v. Cell Host Microbe. 2021 Jun 9;29(6):917-929.e4. doi: 10.1016/j.chom.2021.04.015. Epub 2021 May 3. Cell Host Microbe. 2021. PMID: 33984285 Free PMC article.
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma.
Malin JJ, Di Cristanziano V, Horn C, Pracht E, Garcia Borrega J, Heger E, Knops E, Kaiser R, Böll B, Lehmann C, Jung N, Borchmann P, Fätkenheuer G, Klein F, Hallek M, Rybniker J. Malin JJ, et al. Among authors: di cristanziano v. Blood Adv. 2022 Mar 8;6(5):1580-1584. doi: 10.1182/bloodadvances.2021006655. Blood Adv. 2022. PMID: 34911078 Free PMC article. No abstract available.
68 results